hbeab

The sequence analysis of HBV gene isolated from both HBeAg and HBeAb positive patients

HBeAg、HBeAb双阳性患者血清中病毒前C区基因序列分析

HBV DNA positive rates were high to 77.8-78.6 % in changing cases of serum HbeAb .

在出现HBeAb血清转换组中，HBVdna阳性率高达77.8%～78.6%；

System an ELISA for measurement of HBeAg and HBeAb

ELISA法以单一单克隆抗－HBe测定e系统的研究

The mutations of hepatitis B virus core promoter gene isolated from both HBeAg and HBeAb positive patients

HBeAg/HBeAb双阳性者血清病毒C基因启动子热点变异分析

The number of NK cell in peripheral blood of patients with HBeAb and HBcAg positive chronic hepatitis B

HBeAb及HBcAg均阳性的慢性乙型肝炎患者外周血NK细胞数的研究

The relation and clinical meaning of serum HBeAg , HBeAb and HBV DNA levels in patients with chronic hepatitis B virus infection

慢性HBV感染者血清HBeAg、抗-HBe与HBVdna含量的关系及临床意义

Hepatic function test was performed and HBeAg , HBeAb and HBV DNA were detected at regular intervals in all patients .

治疗期间定期检测肝脏功能、血清HBeAg、HBeAb和HBVdna。

To investigate the relationship between HBeAg / HBeAb and IL 12 in the peripheral blood of HBV infected patients .

探讨乙型肝炎病毒（HBV）感染患者外周血白细胞介素-12（IL-12）水平与HBeAg/HBeAb的关系。

Results Normalization rate of hepatic function , HBV DNA seroconversion rate and HBeAg / HBeAb seroconversion rate in two treatment groups were significantly higher than those in control group .

结果治疗组A和治疗组B的HBVdna阴转率和HBeAg/HBeAb转换率均明显高于对照组。

The patients were then subdivided into the effective group and the ineffective group according to HBV-DNA replication index and the situation of the conversion of HBeAg into HbeAb .

并根据HBV-DNA复制指标及HBeAg/HBeAb转换情况将治疗组分为有效组与无效组。

In 20 samples which were shown HBeAg positive by ABC method but negtive by the other , the results of neutralization tests by HBeAb were all positive .

在20份ABC法HBeAg阳性而普通法阴性的血清中，用抗-HBe作中和抑制试验，抑制率均>50%；

In HBsAg and HBcAg positive while HBeAg and HBeAb negative samples , positive rate of Pre-S1 was 26.9 % , HBV-DNA was 23.0 % .

HBSAg+、HBCAg+、e系统为阴性的前S1阳性率为26.9%，HBV-DNA的阳性率为23.0%。

Gastric mucosal HBsAg positive rate was closely related to positive items of HBsAg , HBsAb , HBeAg , HBeAb , HBcAb in blood ( P < 0.01 ) .

胃粘膜HBsAg阳性率与血液中乙肝五项阳性项数增加呈正相关（P<0.01）。

76 fetuses whose HBV-M positive in cord blood had 8 type HBV-M : 36 HBeAb ( + ) and HBcAb ( + )( 47.4 % );

76例胎儿乙肝血清标志物模式有8种：抗-HBe、抗-HBc阳性36例（47.4%）；

The combination model of serologic markers for HBsAg positive had 5 types , the highest positive rate of HBsAg with HBcAb was 39.0 % , the next with HBeAb and HBcAb was 36.6 % .

HBsAg阳性者五项血清标志物组合模式共5类，与HBcAb同时阳性比例最高39.0%，居次位的是与HBeAb、HBcAb同时阳性占36.6%。

BCP mutant was more often than pre-c gene mutant in both HBeAg group and HBeAb group ( P < 0.05 ) and the two kinds of mutants were of no correlations ( P < 0.05 ) .

不论e抗体阳性组还是e抗原阳性组，BCP变异均高于前C基因变异（P<0.05），但二者均不相关（P>0.05）。

In the 150 patients with positive HBsAg , HBeAb and HbcAb , 56 were found positive pre-S1 , and the positive rate was 37.33 % . 61 cases were HBV-DNA-positive with the positive rate of 40.67 % .

150例HBsAg、HBeAb、HBcAb阳性患者血清检测出前S1抗原56例，阳性率为37.33%，HBV-DNA阳性例数和阳性率分别为61例，40.67%。

When HBV-DNA level in sera was less than 1 × 10 ~ 6 copies / ml , the positive rate of HBeAb decreased as the HBV-DNA level increased and the rates among each groups were remarkably different ( P < 0.05 ) .

HBV-DNA<1×106/ml，HBeAb有较高的阳性率，并随着HBV-DNA含量的增加而逐渐下降，不同组间的HBeAb阳性率相比差异有显著性（P<0.05）。

The consistency rates of HBsAg , HBeAg and HBcAb positive mode , HBsAg , HBcAb positive mode and the HBsAg , HBeAb , HBcAb positive mode to HBV DNA positivity were 94.38 % , 38.56 % and 27.30 % respectively .

HBsAg、HBeAg、HBcAb阳性模式、HBsAg、HBcAb阳性模式和HBsAg、HBeAb、HBcAb阳性模式与HBVdna阳性的符合率分别为94.38%、38.56%、27.30%。

A study of the gastric mucosal HBsAg in 30 patients with gastric diseases ( 17 cases relating to hepatitis or positive HBsAg , HBsAb , HBeAg , HBeAb and HBcAb , and 13 cases nothing relating to them ) was made by immuno-histochemical methods .

本文通过免疫组化对17例与肝炎或乙肝五项阳性有关的，13例与之无关的共30例胃病患者的胃粘膜进行了HBsAg的检测。